Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: AstraZeneca Camizestrant FDA Delay

Lucid Diligence Brief: AstraZeneca Camizestrant FDA Delay Raises SERENA-6…


Women's_Health

Women’s Health Today—May 27, 2026

This biweekly Women’s Health video recap highlights regulatory progress,…


Onco_background

Oncology Today—May 25, 2026

This week’s Oncology update highlights regulatory progress, biomarker-driven…


Cardiovascular

Cardiovascular Today—May 21, 2026

This week’s Cardiovascular update highlights regulatory approvals, late-stage…


Onco_background

Oncology Today—May 18, 2026

This week’s Oncology update highlights regulatory approvals, breakthrough…


Women's_Health

Women’s Health Today—May 13, 2026

This biweekly Women’s Health video recap highlights regulatory actions,…


Artificial_Intelligence

AI in Healthcare and Digital Health Today—May 12, 2026

This week’s AI in Healthcare and Digital Health update highlights…


Onco_background

Oncology Today—May 4, 2026

This week’s Oncology update highlights regulatory approvals, NDA submissions…


Respiratory

Respiratory Today—April 30, 2026

This week’s Respiratory update highlights regulatory approvals, advancing…


Immunology

Immunology Today—April 29, 2026

This week’s Immunology update highlights regulatory actions, clinical progress,…


Respiratory

Respiratory Today—April 24, 2026

This week’s Respiratory Research update highlights regulatory approvals,…


Rare Disease news

Rare Diseases Today—April 23, 2026

This week’s Rare Diseases update highlights late-stage clinical progress,…


Privacy Preference Center